OraSure Technologies, Inc. $OSUR Shares Sold by Acadian Asset Management LLC

Key Points

• Acadian Asset Management LLC has reduced its stake in OraSure Technologies by 5.0%, selling 144,452 shares in the first quarter, and now holds approximately 2.75 million shares valued at around $9.28 million.
• Several investors, including American Century Companies Inc. and Millennium Management LLC, have increased their stakes in OraSure Technologies, indicating a significant interest from institutional investors, who own 93.50% of the stock.
• Analysts have generally rated OraSure Technologies as a "hold" with an average price target of $3.00, following recent upgrades and reaffirmations from firms like Wall Street Zen and Evercore ISI.

Acadian Asset Management LLC lowered its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 5.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,755,266 shares of the medical instruments supplier's stock after selling 144,452 shares during the quarter. Acadian Asset Management LLC owned about 3.68% of OraSure Technologies worth $9,279,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of OSUR. Private Management Group Inc. acquired a new stake in OraSure Technologies during the first quarter valued at approximately $14,886,000. Gagnon Securities LLC acquired a new stake in OraSure Technologies during the first quarter valued at approximately $3,619,000. D. E. Shaw & Co. Inc. raised its position in shares of OraSure Technologies by 180.5% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,517,541 shares of the medical instruments supplier's stock worth $5,478,000 after purchasing an additional 976,475 shares during the period. Gagnon Advisors LLC acquired a new stake in shares of OraSure Technologies during the 1st quarter worth approximately $2,687,000. Finally, Systematic Financial Management LP raised its position in shares of OraSure Technologies by 33.7% during the 4th quarter. Systematic Financial Management LP now owns 1,673,609 shares of the medical instruments supplier's stock worth $6,042,000 after purchasing an additional 421,497 shares during the period. Institutional investors and hedge funds own 93.50% of the company's stock.

OraSure Technologies Stock Performance

Shares of OraSure Technologies stock traded up $0.05 on Thursday, reaching $3.34. 158,050 shares of the company were exchanged, compared to its average volume of 737,886. The company's 50-day moving average is $3.13 and its two-hundred day moving average is $3.06. The firm has a market cap of $243.92 million, a price-to-earnings ratio of -4.98 and a beta of 0.44. OraSure Technologies, Inc. has a 1-year low of $2.36 and a 1-year high of $4.60.

OraSure Technologies Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.